BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 12454848)

  • 41. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes.
    Nanji AA; Jokelainen K; Tipoe GL; Rahemtulla A; Thomas P; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G321-7. PubMed ID: 12388178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S
    Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.
    Ukil A; Maity S; Das PK
    Br J Pharmacol; 2006 Sep; 149(1):121-31. PubMed ID: 16880762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Berberine ameliorates TNBS-induced colitis by inhibiting lipid peroxidation, enterobacterial growth and NF-κB activation.
    Lee IA; Hyun YJ; Kim DH
    Eur J Pharmacol; 2010 Dec; 648(1-3):162-70. PubMed ID: 20828550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Xia Q
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Activation of nuclear factor-kappa B and its modulalorg effects on intercellular adhesion molecule-1 expression in mice with dextran sulphate sodium-induced rat colitis].
    Yang MS; Long YM; Cui SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):600-2. PubMed ID: 18495601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
    Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
    J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease].
    Dubuquoy L; Bourdon C; Peuchmaur M; Leibowitz MD; Nutten S; Colombel JF; Auwerx J; Desreumaux P
    Gastroenterol Clin Biol; 2000; 24(8-9):719-24. PubMed ID: 11011247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of trinitrobenzene sulfonic acid-induced experimental colitis by oral administration of a poly(lactic-coglycolic acid) microsphere containing prostaglandin E₂ receptor subtype 4 agonist.
    Okamoto T; Uemoto S; Tabata Y
    J Pharmacol Exp Ther; 2012 May; 341(2):340-9. PubMed ID: 22300734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
    Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
    J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
    Singer M; Trugnan G; Chelbi-Alix MK
    Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
    Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
    J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
    Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
    Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
    Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ
    Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The guggulsterone derivative GG-52 inhibits NF-κB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout mice.
    Kang SJ; Kim JM; Koh SJ; Kim SH; Im JP; Jung HC; Kim JS
    Life Sci; 2013 Jun; 92(22):1064-71. PubMed ID: 23603141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrarectal administration of milk fat globule epidermal growth factor-8 protein ameliorates murine experimental colitis.
    Otani A; Ishihara S; Aziz MM; Oshima N; Mishima Y; Moriyama I; Yuki T; Amano Y; Ansary MM; Kinoshita Y
    Int J Mol Med; 2012 Mar; 29(3):349-56. PubMed ID: 22200667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats.
    Park SY; Neupane GP; Lee SO; Lee JS; Kim MY; Kim SY; Park BC; Park YJ; Kim JA
    Arch Pharm Res; 2014 Feb; 37(2):253-62. PubMed ID: 24166708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
    Bhatia M; Landolfi C; Basta F; Bovi G; Ramnath RD; de Joannon AC; Guglielmotti A
    Inflamm Res; 2008 Oct; 57(10):464-71. PubMed ID: 18827968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.